info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Minimally Invasive Glaucoma Surgery Devices Market By Product Type (Trabecular Micro-Bypass, Canaloplasty Devices, Shunts, Biodegradable Implants, Others); By Surgical Approach (Ab-Interno, Ab-Externo); By End User (Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Minimally Invasive Glaucoma Surgery ( MIGS ) Devices Market is projected to grow at a robust CAGR of 9.1% , reaching an estimated USD 2.3 billion ... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Veterinary Regenerative Medicine Market By Therapy Type (Cell Therapy, PRP Therapy, Tissue Engineering, Others); By Animal Type (Companion Animals, Equine, Livestock, Others); By Application (Orthopedics, Wound Healing, Neurology, Internal Organ Repair); By End User (Specialty Veterinary Hospitals, Equine Clinics, General Veterinary Clinics, Academic/Teaching Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Veterinary Regenerative Medicine Market will witness a robust CAGR of 18.4%, valued at USD 1.3 billion in 2024 , and projected to reach nearly USD... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Cardiac Troponin Market By Assay Type (Conventional Troponin, High-Sensitivity Troponin); By Sample Type (Venous Blood, Capillary Blood); By Testing Location (Hospital Labs, Point-of-Care, Diagnostic Labs); By End User (Hospitals, Diagnostic Labs, Urgent Care Clinics, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Troponin Market will witness a steady CAGR of 6.5%, valued at approximately USD 5.2 billion in 2024 and projected to reach around... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Cardiac Tissue Engineering Market By Product Type (Cardiac Patches, Injectable Hydrogels, Bioprinted Tissues, Others); By Application (Ischemic Heart Disease, Heart Failure, Congenital Defects, Others); By End User (Academic and Research Institutes, Specialized Cardiac Centers, General Hospitals, Pharmaceutical and Biotech Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Tissue Engineering Market will grow at a CAGR of 11.8% , valued at around USD 1.3 billion in 2024 and projected to reach USD 2.8 billion b... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Ultomiris Drug Market By Product Type (Intravenous, Subcutaneous); By Indication (Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder, Pediatric Rare Diseases); By End User (Hospitals, Specialty Clinics & Infusion Centers, Retail Pharmacies, Pediatric Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ultomiris Drug Market will witness a CAGR of 9.7% , valued at USD 4.6 billion in 2024 and expected to reach USD 8.2 billion by 20... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Vitreous Tamponades Market By Product Type (Silicone Oils, Gas Tamponades [C3F8, SF6, Air Mixtures], Emerging Agents); By Application (Retinal Detachment Surgery, Macular Hole Repair, Proliferative Vitreoretinopathy, Diabetic Retinopathy Complications); By End User (Hospitals & Specialty Eye Centers, Ambulatory Surgical Centers, Research & Academic Institutes, General Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vitreous Tamponades Market will expand steadily at an CAGR of 6.1% , valued at USD 475.0 million in 2024 and projected t... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Mammalian Polyclonal IgG Antibody Market By Source (Rabbit, Goat, Horse, Sheep); By Application (Diagnostics, Research, Drug Discovery); By End User (Academic and Research Institutes, Biopharma Companies, Diagnostic Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mammalian Polyclonal IgG Antibody Market is set to grow at a CAGR of 8.1% , valued at USD 1.8 billion in 2024 , and projected to reach around USD ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Nuclear Cardiology Market By Product Type (SPECT, PET, Hybrid Imaging Systems); By Application (Coronary Artery Disease, Cardiomyopathy, Heart Failure, Others); By End User (Hospitals, Diagnostic Imaging Centers, Cardiology Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nuclear Cardiology Market will grow at an estimated CAGR of 6.8%, valued at around USD 2.9 billion in 2024 , and projected to reach nearly USD 4.3 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Pharmaceutical Water Market By Product Type (Purified Water, Water for Injection, Highly Purified Water, Others); By Production Method (Distillation, Membrane-Based, Hybrid Systems); By End User (Pharmaceutical Companies, Biotechnology Firms, Contract Manufacturing Organizations, Research & Academic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Water Market will witness a steady CAGR of 6.5% , valued at USD 8.7 billion in 2024 , and projected to reach Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Oral Iron Supplements Market By Product Type (Ferrous Sulfate, Ferrous Gluconate, Ferric Citrate, Others); By Route of Administration (Tablets, Capsules, Liquid, Gummies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oral Iron Supplements Market will witness a steady CAGR of 6.8%, valued at USD 3.1 billion in 2024, and is expected to reach USD 4.6 billion by 2030, acco... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Minimally Invasive Spine Surgery Market By Procedure Type (Discectomy, Spinal Fusion, Decompression, Motion Preservation Techniques); By Device Type (Retractors, Implants, Navigation Systems, Robotics, Biologics); By Surgical Approach (Posterior, Anterior, Lateral, Transforaminal); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Spine Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Minimally Invasive Spine Surgery Market is projected to grow at a steady CAGR of 6.8%, reaching an estimated value of USD 14.9 billion by 2030, up from an market size of <... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Aicardi Goutieres Syndrome Market By Treatment Type (Symptomatic Therapy, Experimental/Investigational Therapies); By Route of Administration (Oral, Parenteral, Emerging Routes); By End User (Specialty Hospitals, Academic & Research Institutes, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aicardi Goutieres Syndrome (AGS) Market will witness a steady CAGR of 7.8% , valued at USD 92 million in 2024 , and is projected to reach... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

RNA Polymerase Market By Product Type (Bacterial RNA Polymerase, Phage RNA Polymerase, Eukaryotic RNA Polymerase); By Application (mRNA Therapeutics, Vaccine Manufacturing, Molecular Diagnostics, Synthetic Biology, Research); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RNA Polymerase Market will witness a steady CAGR of 6.8%, valued at $820 million in 2024, and is expected to reach nearly $1.22 b... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Chronic Venous Insufficiency Treatment Market By Treatment Type (Compression Therapy, Pharmacological Therapy, Endovenous Ablation, Sclerotherapy, Surgical Vein Stripping); By Disease Severity (Early-Stage CVI, Moderate CVI, Severe CVI); By End User (Hospitals, Specialized Vascular Clinics, Ambulatory Surgical Centers, Diagnostic & Primary Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Venous Insufficiency Treatment Market will grow at a CAGR of 6.5% , valued at USD 3.9 billion in 2024 , and expected to reach USD 6.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Thromboembolic Pulmonary Hypertension Market By Treatment Modality (Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, Pharmacotherapy); By Drug Class (Soluble Guanylate Cyclase Stimulators, Prostacyclin Analogs, Endothelin Receptor Antagonists, Anticoagulants); By End User (Specialized CTEPH Centers, Tertiary Hospitals, General Hospitals, Diagnostic & Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Market will witness a robust CAGR of 6.8% , valued at USD 1.7 billion in 2024 , exp... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Cocaine Intoxication Treatment Market By Product Type (Benzodiazepines, Cardiovascular Stabilizers, Antipsychotics, Emerging Pharmacotherapies); By Route of Administration (Oral, Intravenous, Intramuscular, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cocaine Intoxication Treatment Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 6.5% . The market is valued at USD 1.8 billion in 2024 a... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Super Resolution Microscope Market By Technology Type (STED, STORM & PALM, SIM, Others); By Application (Cell Biology & Neuroscience, Cancer Research, Microbial Imaging, Drug Discovery, Nanomaterials); By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Industrial Research Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Super Resolution Microscope Market is projected to expand at a steady pace between 2024 and 2030, with a CAGR of 9.8% . The market is valued at approximately USD 4... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Charging Oxygen Gas Systems Market By System Type (Cylinder Charging Systems, Onboard Oxygen Charging Units, Centralized Oxygen Charging Systems); By Application (Healthcare, Aerospace and Defense, Industrial Manufacturing, Other Specialized Uses); By End User (Hospitals and Clinics, Defense Forces, Industrial Facilities, Emergency Services and Mobile Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Charging Oxygen Gas Systems Market will witness a steady CAGR of 6.5%, valued at USD 2.4 billion in 2024, and projected to reach USD 3.7 billion by 2030 ,... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Complement 3 Glomerulopathy Treatment Market By Drug Class (Complement Inhibitors, Immunosuppressants, Corticosteroids, Others); By Route of Administration (Intravenous, Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement 3 Glomerulopathy Treatment Market will witness a robust CAGR of 10.2%, valued at USD 615.0 million in 2024 , expected to reach... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cold Agglutinin Disease Treatment Market By Drug Class (Monoclonal Antibodies, Immunosuppressants, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Agglutinin Disease ( CAD ) Treatment Market will witness a steady CAGR of 8.1%, valued at USD 620.0 million... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Disposable Lead Wires Market By Material (TPE, TPU, PVC, Silicone); By Usability (Disposable, Reusable); By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Disposable Lead Wires Market is poised for steady growth between 2024 and 2030, with an estimated value of USD 1.6 billion in 2024 , projected to reach around USD<... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Vernal Keratoconjunctivitis Market By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Biologics); By Route of Administration (Eye Drops, Gels, Ocular Inserts); By Patient Age Group (Pediatric, Adolescent, Adult-Onset); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vernal Keratoconjunctivitis Market is projected to grow at a CAGR of 6.8% , valued at USD 332.0 million in 2024 , and ex... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Mutant p53 Reactivator and p53 Restoration Therapeutics Market By Therapeutic Strategy (Mutation-specific p53 Reactivation, Broader p53 Pathway Reactivation, p53 Restoration Approaches); By Cancer Type (Breast, Ovarian, Lung, AML/MDS, Head and Neck); By Modality (Small-Molecule, Pathway Activators, Gene-Based Therapies); By End User (Academic Medical Centers, Specialized Cancer Hospitals, Research-Driven Clinics); By Region, Segment Revenue Estimation, Forecast, 2025–2035

Introduction And Strategic Context

The Global Mutant p53 Reactivator and p53 Restoration Therapies Market is positioned at a pre-approval stage, valued at approximately USD 1.9 billion in 2025, and projected to reach ... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Stem Cell Exosome Therapeutics Market By Product Type (Natural Exosomes, Engineered Exosomes); By Application (Oncology, Neurology, Wound Healing & Dermatology, Inflammatory & Autoimmune Disorders); By Route of Administration (Injectable, Topical, Intranasal, Oral); By End User (Academic & Research Institutes, Biotech & Pharma Companies, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stem Cell Exosome Therapeutics Market is poised for accelerated growth, witnessing a projected CAGR of 27.5%, valued at USD 0.82 billion in 2024 and expec... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Rare NRG1 Fusion Market By Therapy Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, RNA Therapies & Antibody-Drug Conjugates); By Cancer Type (Non-Small Cell Lung Cancer, Pancreatic Cancer, Others); By Diagnostic Method (CGP via NGS, FISH & RT-PCR); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rare NRG1 Fusion Market is projected to grow at a CAGR of 37.8% , with an estimated valuation of $ 187.0 million... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Pulmonary Alveolar Proteinosis Drug Market By Drug Type (GM-CSF Therapies, Off-Label Immunomodulators, Investigational Biologics); By Route of Administration (Inhalation, Subcutaneous, Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Alveolar Proteinosis Drug Market will witness a steady CAGR of 5.8% , valued at USD 182 million in 2024 , expected to reach around USD 255 million by 203... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Positive Allosteric Modulators Market By Target Receptor (GABA-A, mGluR, Muscarinic, Others); By Application (Neurology, Psychiatry, Metabolic, Inflammatory); By Molecule Type (Small Molecules, Peptides, Biologics); By End User (Pharmaceutical Companies, Research Institutes, Specialty Clinics, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Positive Allosteric Modulators Market is projected to expand at a steady CAGR of 6.7%, valued at USD 1.9 billion in 2024 , and expected to reach U... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Oncogene Inhibitor Market By Type (Tyrosine Kinase Inhibitors, Monoclonal Antibodies, Serine/Threonine Kinase Inhibitors, Fusion Protein Inhibitors, Others); By Indication (Non-Small Cell Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Pancreatic Cancer, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oncogene Inhibitor Market is projected to grow at a CAGR of 9.6% , rising from an estimated USD 6.7 billion in 2024 to around USD 11.8 billion by 2030 , a... Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Non-Cystic Fibrosis Bronchiectasis Market By Treatment Type (Inhaled Antibiotics, Oral Antibiotics, Bronchodilators, Anti-inflammatory Therapies); By Diagnostic Modality (High-Resolution CT, Pulmonary Function Testing, Microbiological Testing); By End User (Hospitals, Pulmonology Clinics, Specialty Pharmacies, Homecare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Cystic Fibrosis Bronchiectasis Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated USD 2.1 billion by 2030 , up from around USD 1.4 bi... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Neoantigen Cancer Vaccine Market By Technology Platform (mRNA-based, Peptide-based, DNA-based, Dendritic Cell-based); By Cancer Type (Melanoma, NSCLC, Colorectal, Pancreatic, Glioblastoma, Others); By Delivery Mechanism (Lipid Nanoparticle, Intradermal Injection, Electroporation); By End User (Academic Cancer Centers, Specialty Oncology Hospitals, CROs, Immunotherapy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Cancer Vaccine Market is projected to grow at a robust CAGR of 24.7% from 2024 to 2030, starting at an estimated USD 1.2 billion in 2024 and re... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

mRNA Therapeutics Market By Product Type (mRNA Vaccines, mRNA Therapeutics); By Application (Infectious Diseases, Oncology, Genetic Disorders, Autoimmune Diseases, Cardiovascular and Others); By Route of Administration (Intramuscular, Intravenous, Inhalation/Intranasal); By End User (Hospitals & Academic Centers, Public Health Agencies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Therapeutics Market is projected to expand at a strong pace, valued at approximately USD 45.2 billion in 2024 and expected to reach around USD 98.7 billion by... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Molecular Glue Degrader Market By Target Protein (IKZF1/3, GSPT1, BCL6, STAT3, BRD9, Others); By Indication (Oncology, Neurology, Immunology, Others); By End User (Biopharma Companies, Academic Research Centers, CROs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Molecular Glue Degrader Market will witness a robust CAGR of 36.8%, valued at USD 413.0 million in 2024 , and expected to reach around Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Kinase Inhibitor in Autoimmune Diseases Market By Product Type (JAK Inhibitors [JAK1/2/3, TYK2], BTK Inhibitors, SYK & Other Kinase Targets); By Therapeutic Application (Rheumatoid & Psoriatic Arthritis, Dermatology [Atopic Dermatitis, Psoriasis, Alopecia, Vitiligo], Gastroenterology [Ulcerative Colitis, Crohn’s Disease], Neurology [Multiple Sclerosis, Myasthenia Gravis], Others); By Route of Administration (Oral, Topical, Injectable/Emerging Delivery); By Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Kinase Inhibitor In Autoimmune Diseases Market will witness a robust CAGR of 9.1% , valued at $14.6 billion in 2024 , expected to appreci... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Intratumoral Cancer Therapies Market By Therapy Type (Oncolytic Viruses, Cytokine-Based Therapies, Gene Therapies, Small Molecule Injectables); By Cancer Type (Melanoma, Head and Neck, Breast, Lung, Pancreatic, Brain Tumors); By Route of Administration (Image-Guided Injection, Intraoperative Delivery, Endoscopic Injection); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Intratumoral Cancer Therapies Market is expected to grow at a robust CAGR of 10.6% , valued at an estimated USD 1.3 billion in 2024 , and... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Interstitial Lung Disease Market By Disease Type (IPF, CTD-ILD, HP, Occupational/Environmental, Sarcoidosis, Drug-Induced, Others); By Drug Class (Antifibrotics, Corticosteroids, Immunosuppressants, Biologics, Novel Agents); By Route of Administration (Oral, Inhalation, Injectable); By Diagnostic Tool (HRCT, PFTs, Biomarkers, Genetic Testing, Lung Biopsy); By End User (Tertiary Hospitals, Specialist Clinics, Imaging Centers, Community Hospitals, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Interstitial Lung Disease Market is expected to grow at a steady CAGR of around 6.1% , valued at USD 4.7 billion in 2024 and projected to reach nearly USD 6.7 bill... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

IgA Nephropathy Market By Therapy Type (Corticosteroid-Sparing Therapies, Endothelin Receptor Antagonists, Complement Inhibitors, Supportive Care); By Route of Administration (Oral, Injectable); By End User (Academic and Tertiary Hospitals, Specialty Nephrology Clinics, Retail and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global IgA Nephropathy Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated market size of USD 5.8 billion by 2030 , up ... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

HER2 Positive Gastric Cancer Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Tyrosine Kinase Inhibitors, Immunotherapies); By Line of Treatment (First-Line, Second-Line, Third-Line & Beyond); By Diagnostic Modality (IHC, FISH, NGS); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global HER2 Positive Gastric Cancer Market will witness a steady CAGR of 6.8% , valued at USD 3.7 billion in 2024 , and projected to reach nearl... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Hematopoietic Stem Cells Transplantation Market By Transplant Type (Autologous, Allogeneic); By Source of Stem Cells (Bone Marrow, Peripheral Blood, Umbilical Cord Blood); By Application (Oncology, Hematology, Rare Genetic Disorders); By End User (Academic Hospitals, General Hospitals, Specialty Transplant Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hematopoietic Stem Cells Transplantation ( HSCT ) Market will expand at a robust CAGR of 8.1% , valued at USD 6.7 billion in 2024 and pro... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Gene and Cell Therapies Targeting CNS Disorders Market By Therapy Type (Gene Therapy, Cell Therapy, Gene-Modified Cell Therapy); By Indication (Parkinson’s Disease, ALS, SMA, Huntington’s Disease, Alzheimer’s Disease, Rare Pediatric CNS Disorders); By Delivery Method (Intrathecal, Intravenous, Intraparenchymal, Intranasal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene and Cell Therapies Targeting CNS Disorders Market is set to grow at a compelling CAGR of 18.4% , starting from an e... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Fibromyalgia Treatment Market By Drug Class (SNRIs, Anticonvulsants, Tricyclic Antidepressants, Muscle Relaxants, Others); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibromyalgia Treatment Market is projected to grow at a compound annual growth rate of 5.2 % , reaching an estimated value of USD... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

DiGeorge Syndrome Drug Market By Drug Class (Immunomodulators and Immunoglobulins, Hormone Replacement Therapies, Antipsychotics and Behavioral Medications, Supportive Medications); By Therapeutic Target (Immune System Dysfunction, Endocrine and Metabolic Dysfunction, Neurodevelopmental and Psychiatric Symptoms, Congenital Heart Defects and Surgical Support); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies and Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digeorge Syndrome Drug Market is projected to grow at a CAGR of 8.1% from 2024 to 2030 , moving from an estimated USD 328Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Cutaneous Lupus Erythematosus Market By Disease Subtype (Acute CLE, Subacute CLE, Chronic CLE); By Treatment Class (Topical Agents, Antimalarials, Immunosuppressants, Biologics & Small Molecules); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cutaneous Lupus Erythematosus (CLE) Market is projected to expand at a CAGR of 6.4% , reaching USD 3.1 billion by 2030 , up from USD 2.1 billion i... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

COMT Inhibitors Market By Drug Type (Entacapone, Tolcapone, Opicapone); By Application (Parkinson’s Disease, Neurological Disorders); By Route of Administration (Oral); By End User (Hospitals, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global COMT Inhibitors Market is projected to grow at a steady pace, with a Compound Annual Growth Rate ( CAGR ) Of 6.8% , reac... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Chronic Spontaneous Urticaria Treatment Market By Treatment Type (Antihistamines, Biologics, Leukotriene Receptor Antagonists, Corticosteroids, Others); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Spontaneous Urticaria (CSU) Treatment Market is projected to expand steadily between 2024 and 2030, driven by a combination of rising disease prev... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Chronic Rhinosinusitis With Nasal Polyps Market By Treatment Type (Corticosteroids, Biologics, Surgery, Others); By Route of Administration (Intranasal, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Rhinosinusitis With Nasal Polyps Market will witness a steady CAGR of 6.8% , valued at USD 5.1 billion in 2024 , expected to reac... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market By Drug Class (Bronchodilators, Corticosteroids, PDE-4 Inhibitors, Combination Therapies, Others); By Route of Administration (Inhalation, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is projected to grow at a steady CAGR of 6.1% , with an estimated value of USD 20.1 ... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Chronic Lymphocytic Leukemia Market By Therapy Type (Chemo-Immunotherapy, BTK Inhibitors, BCL2 Inhibitors, Others); By Diagnostics (MRD Assays, Cytogenetic Testing, Flow Cytometry, Others); By End User (Hospitals, Specialist Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Lymphocytic Leukemia Market will witness a steady CAGR of 6.1 % ,valued at around 10.6 billion US dollars in 2024Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Inducible Urticaria Treatment Market By Drug Class (Antihistamines, Leukotriene Receptor Antagonists, Biologics, Immunosuppressants); By Route of Administration (Oral, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Inducible Urticaria Treatment Market is estimated to be valued at around $1.3 billion in 2024 and is projected to reach roughly $2.1 billion by 2030 , rising at a ... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Chondrosarcoma Market By Type (Conventional, Dedifferentiated, Mesenchymal, Clear Cell); By Treatment Modality (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy); By End User (Academic Hospitals, Orthopedic Oncology Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondrosarcoma Market is poised for steady growth between 2024 and 2030, driven by expanding research pipelines, better diagnostics, and heightened awareness across rare bone tumors . While exact numbers f... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Chemotherapy-Induced Diarrhea Treatment Market By Treatment Type (Anti-Diarrheal Agents, Oral Rehydration Solutions, Probiotics, Biologics); By Chemotherapy Regimen (Fluoropyrimidines, Irinotecan, Combination Therapies, Others); By End User (Hospitals & Oncology Centers, Outpatient Clinics & Homecare, Pharmacies & Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chemotherapy-Induced Diarrhea Treatment Market is projected to witness a robust CAGR of 6.8%, valued at USD 1.2 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chemotherapy Induced Peripheral Neuropathy Treatment Market By Drug Class (Antidepressants, Anticonvulsants, Topical Agents, Opioids, Neuroprotective Agents); By Mechanism of Action (Pain Modulation, Neuroprotection, Nerve Regeneration); By Route of Administration (Oral, Injectable, Transdermal); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Chemotherapy Induced Peripheral Neuropathy ( CIPN ) Treatment Market is projected to grow at a CAGR of 7.3 %, reaching a... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Checkpoint Inhibitor Refractory Cancer Market By Therapy Type (T-cell Engagers, Next-Generation Checkpoint Modulators, Cell Therapies, Small Molecule Immunomodulators, Combination Therapies); By Cancer Type (Melanoma, NSCLC, RCC, HNSCC, Others); By End User (Academic Cancer Centers, Specialty Oncology Clinics, General Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Checkpoint Inhibitor Refractory Cancer Market will witness a robust CAGR of 9.6% , valued at USD 8.3 billion in 2024 , and expected to reach around USD 14.4 billio... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Cereblon E3 Ligase Modulators Market By Product Type (First-Generation IMiDs, Next-Generation Protein Degraders); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By End User (Hospital Oncology Departments, Specialty Cancer Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cereblon E3 Ligase Modulators Market will witness a robust CAGR of 12.5%, valued at an estimated USD 2.1 billion... Read More

Published Date: DEC-2025 | No Of Pages:183 | $ 4485

CEACAM5 Drugs Market By Drug Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Therapies, Bispecific Antibodies); By Indication (Colorectal Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, Other Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CEACAM5 Drugs Market will witness a robust CAGR of 8.1%, valued at USD 2.1 billion in 2024, expected to appreciate and reach USD ... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

CD38 Monoclonal Antibody Drugs Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Multiple Myeloma, Chronic Lymphocytic Leukemia, Autoimmune Disorders, Other Hematologic Malignancies); By Distribution Channel (Hospital Pharmacies, Community Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD38 Monoclonal Antibody Drugs Market is projected to expand steadily between 2024 and 2030 , with an estimated value of USD 8.1 billion in 2024 and likel... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Catheter Related Bloodstream Infection Market By Product Type (Antimicrobial Catheters, CHG Dressings, Needleless Connectors, Catheter Lock Solutions); By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Fungal Pathogens); By End User (Hospitals, Dialysis Clinics, Infusion Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Catheter-Related Bloodstream Infection (CRBSI) Market is projected to grow steadily at a CAGR of 6.5% , reaching nearly USD 2.35 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Cardiac Amyloidosis Market By Product Type (Transthyretin Stabilizers, RNA Interference Therapies, Antisense Oligonucleotides, Monoclonal Antibodies, Diagnostics); By Application (Transthyretin Amyloidosis [Hereditary, Wild-type], Light Chain Amyloidosis); By End User (Hospitals, Specialty Cardiac Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Amyloidosis Market will grow at a CAGR of 10.8% , valued at USD 4.2 billion in 2024 , and projected to reach USD 7.8 billion by 2030 , according t... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Cancer Tubulin Inhibitors Market By Drug Class (Vinca Alkaloids, Taxanes, Colchicine Site Binders, Synthetic Analogs); By Indication (Breast Cancer, Lung Cancer, Ovarian Cancer, Lymphomas, Leukemias, Rare Malignancies); By Route of Administration (Intravenous, Oral, Long-acting Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Tubulin Inhibitors Market is set to grow at a robust CAGR of 6.8% , valued at USD 2.1 billion in 2024 , and projected to reach USD 3.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Cancer CDK Inhibitors Market By Drug Type (CDK4/6 Inhibitors, CDK7 Inhibitors, CDK9 Inhibitors, Multi-Target CDK Inhibitors); By Indication (Breast Cancer, Lung Cancer, Ovarian Cancer, Hematologic Malignancies, Others); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer CDK Inhibitors Market is projected to expand at a robust CAGR of 9.5% , valued at USD 8.2 billion in 2024 and expected to reach around USD 14.2 billion by 2... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Cancer Anorexia Market By Product Type (Appetite Stimulants, Corticosteroids, Progestogens, Cannabinoids, Nutraceuticals, Biologics/Peptides); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Anorexia Market is expected to grow at a CAGR of 6.8% , valued at USD 2.9 billion in 2024 , and projected to reach USD 4.3 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Cancer Angiogenesis Inhibitors Market By Drug Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Others); By Cancer Type (Colorectal, Lung, Renal, Hepatocellular, Breast, Others); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Oncology Clinics, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Angiogenesis Inhibitors Market will witness an estimated CAGR of 8.1% , valued at USD 15.7 billion in 2024 , and is expected to reach around USD 25.1 billio... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Bullous Pemphigoid Market By Drug Class (Corticosteroids, Immunosuppressants, Antibiotics, Biologics); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Pemphigoid Market is projected to grow at a CAGR of 6.1% , valued at USD 1.7 billion in 2024 and expected to reach USD 2.6 billion by 2030 , accor... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Bullous Keratopathy Market By Treatment Type (Corneal Transplantation [DMEK, DSAEK, Penetrating Keratoplasty], Pharmacological Therapy, Artificial Corneas, Supportive & Symptomatic Treatment); By Cause (Post-Cataract Surgery, Fuchs’ Dystrophy, Trauma, Infection, Congenital Disorders); By End User (Specialty Eye Hospitals, General Hospitals, ASCs, Academic/Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Keratopathy Market is projected to grow steadily from USD 1.12 billion in 2024 to reach around USD 1.61 billion by 2030 , reflecting a CAG... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

BTK Inhibitors Market By Type (Covalent BTK Inhibitors, Reversible BTK Inhibitors); By Application (Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Waldenström’s Macroglobulinemia, Rheumatoid Arthritis, Lupus, Multiple Sclerosis); By End User (Hospitals, Specialty Clinics, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BTK Inhibitors Market will register a strong CAGR of 11.9% , rising from $8.7 billion in 2024 to an estimated $17.2 billion by 20... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Bronchopulmonary Dysplasia Treatment Market By Treatment Type (Corticosteroids, Surfactants, Diuretics, Bronchodilators, Pulmonary Vasodilators); By Route of Administration (Intravenous, Inhalation, Oral, Intratracheal); By End User (NICUs, Pediatric Hospitals, Outpatient Pediatric Clinics, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchopulmonary Dysplasia (BPD) Treatment Market is projected to expand steadily between 2024 and 2030, supported by rising preterm birth rates and advances in neonatal intensive care. Ba... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

BRCA Mutations Treatment Market By Treatment Type (PARP Inhibitors, Hormonal Therapy, Chemotherapy, Targeted Combinations); By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic and Others); By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BRCA Mutations Treatment Market is projected to reach a value of $5.8 billion in 2024 , with expectations to surpass $10.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Bone Metastasis Market By Treatment Type (Pharmaceuticals [Bisphosphonates, RANKL Inhibitors, Radiopharmaceuticals], Radiation Therapy, Surgical Interventions, Supportive Care); By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer, Thyroid & Others); By End User (Hospitals & Cancer Centers, Community Oncology Clinics, Specialty Orthopedic Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Metastasis Market is projected to expand steadily, reaching approximately USD 18.7 billion in 2024 and anticipated to surpass USD 27.9 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Blepharitis Market By Type (Anterior Blepharitis, Posterior Blepharitis, Mixed); By Treatment (Lid Hygiene Products, Prescription Pharmaceuticals, In-Office Procedures, Device-Based Home Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blepharitis Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 5.8% , reaching approximately USD 1.9 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Biliary Atresia Market By Treatment Type (Surgical Interventions, Liver Transplantation, Pharmacological Therapies); By Diagnosis Stage (Early Diagnosis, Delayed Diagnosis); By End User (Tertiary Pediatric Hospitals, Specialty Liver Transplant Units, General Hospitals with Pediatric Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biliary Atresia Market is projected to expand steadily between 2024 and 2030, driven by rising awareness of neonatal liver disorders, earlier diagnostic interventions, and ongoing advances... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Beta Thalassemia Market By Therapy Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy & Gene Editing, Bone Marrow/Stem Cell Transplantation); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Hematology Centers, Specialty Clinics, Retail & Online Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Beta Thalassemia Market is projected to expand steadily between 2024 and 2030, with an estimated valuation of USD 1.9 billion in 2024 and expected to reach USD 3.1... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Benign Prostatic Hyperplasia Treatment Market By Therapy Type (Pharmacological, Minimally Invasive Surgical Therapies, Surgical Procedures); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Urology Clinics); By End User (Hospitals & Teaching Institutions, Specialty Urology Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benign Prostatic Hyperplasia Treatment Market is projected to expand at a 6.9% CAGR, valued at $10.8 billion in 2024 and on track to reac... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

AXL Receptor Tyrosine Kinase Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Monoclonal Antibodies, Antibody-Drug Conjugates); By Application (Oncology, Fibrosis, Inflammatory Diseases); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global AXL Receptor Tyrosine Kinase (RTK) Inhibitors Market is anticipated to grow steadily between 2024 and 2030, with analysts estimating a ma... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Axial Spondyloarthritis Market By Drug Type (Biologics, csDMARDs, tsDMARDs); By Disease Type (Radiographic AxSpA, Non-Radiographic AxSpA); By End User (Hospitals, Specialty Rheumatology Clinics, Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Axial Spondyloarthritis (Axspa) Market is projected to witness a robust CAGR of 7.4 Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Trace Oxygen Analyzer Market By Product Type (Portable, Benchtop, In-line/Process); By Technology (Electrochemical, Zirconia, Paramagnetic, Laser); By Application (Industrial, Medical, Laboratory, Semiconductor, Food & Beverage, Power Generation); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trace Oxygen Analyzer Market is projected to expand at an estimated CAGR of 5.9%, valued at roughly $638 million in 2024 and expected to surpass $900 million by 20... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

PDGFR Inhibitors Market By Drug Type (Monotherapy Inhibitors, Multi-Kinase Inhibitors); By Indication (Gastrointestinal Stromal Tumors, Glioblastoma, Pulmonary Fibrosis, Other Rare Disorders); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PDGFR Inhibitors Market is projected to expand at a healthy pace between 2024 and 2030, with an estimated valuation of USD 3.1 billion in 2024 and expecte... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

Trodelvy Market By Indication (Triple-Negative Breast Cancer, HR+/HER2- Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Others); By Line of Therapy (Second-Line, Third-Line and Beyond, Maintenance); By Distribution Channel (Hospital Pharmacies, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trodelvy Market will experience a strong growth trajectory between 2024 and 2030, rising from an estimated USD 1.62 billion in 2024 to nearly USD ... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Bcr Abl Tyrosine Kinase Inhibitor Drug Market By Drug Generation (First-Generation, Second-Generation, Third-Generation/Mutation-Specific); By Indication (Chronic Myeloid Leukemia, Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, Others); By Route of Administration (Oral, Others); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bcr Abl Tyrosine Kinase Inhibitor Drug Market is set to grow at an CAGR of 6.8%, valued at USD 7.1 billion in 2024, and ... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

PIM Kinase Targeted Therapies Market By Drug Type (Selective PIM Kinase Inhibitors, Dual/Multi-Target Kinase Inhibitors); By Cancer Type (Hematologic Malignancies, Solid Tumors); By Line of Therapy (First-Line, Second-Line and Beyond); By Route of Administration (Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PIM Kinase Targeted Therapies Market is projected to witness strong expansion between 2024 and 2030, with an inferred CAGR of 10.1%. The market is valued at approximately ... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

mRNA Cancer Vaccines Market By Cancer Type (Melanoma, Lung, Pancreatic, Colorectal, Breast, Prostate); By Vaccine Type (Personalized mRNA Vaccines, Off-the-Shelf Vaccines); By Delivery Mechanism (Lipid Nanoparticles, Polymer-Based Carriers, Exosomes); By End User (Academic & Research Institutes, Specialty Oncology Clinics, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Cancer Vaccines Market is projected to grow at a robust pace between 2024 and 2030, with an estimated value of USD 1.8 billion in 2024, expected to r... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

MEK Inhibitors Market By Molecule Type (Trametinib, Cobimetinib, Binimetinib, Selumetinib, Others); By Application (Melanoma, Non-Small Cell Lung Cancer, Colorectal Cancer, Neurofibromatosis Type 1, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online & Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global MEK Inhibitors Market is projected to expand steadily between 2024 and 2030, supported by deeper adoption of targeted oncology therapies and ongoing approvals of next-gene... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Lupus Nephritis Treatment Market By Drug Class (Immunosuppressants, Biologics, Corticosteroids, ACE Inhibitors & ARBs, Antimalarials); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lupus Nephritis Treatment Market is projected to grow at a CAGR of 10.4%, expanding from USD 1.6 billion in 2024 to approximately USD 2.9 billion ... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

SYK Inhibitors Market By Molecule Type (Small Molecule, Biologic); By Indication (Hematological Malignancies, Autoimmune Diseases, Inflammatory Disorders); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global SYK Inhibitors Market is expected to grow at a robust CAGR of 23.5%, estimated at $635 million in 2024 and projected to reach nearly Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Insulin Biosimilar Market By Product Type (Basal, Bolus, Premixed); By Disease Type (Type 1 Diabetes, Type 2 Diabetes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Insulin Biosimilar Market is projected to expand steadily between 2024 and 2030, growing at an estimated CAGR of 9.1%, with market value expected to reach USD 7.8 ... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

TROP2 Antibody Market By Drug Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Breast Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma, Others); By End User (Academic & Research Hospitals, Oncology Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TROP2 Antibody Market will witness a robust CAGR of 20.6%, valued at USD 1.8 billion in 2024, expected to appreciate and reach US... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

CD40 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Fusion Proteins, Small Molecules); By Indication (Oncology, Autoimmune Diseases, Transplantation); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD40 Targeted Therapies Market is projected to grow at a robust CAGR of 11.8%, reaching an estimated valuation of USD 3.9 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Anaplastic Lymphoma Kinase (ALK) Inhibitors Market By Drug Generation (First-Generation, Second-Generation, Third-Generation); By Application (Non-Small Cell Lung Cancer, Anaplastic Large Cell Lymphoma, Pediatric & Rare Cancers); By End User (Cancer Specialty Hospitals, General Hospitals, Outpatient Oncology Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market is positioned for steady expansion over the next several years, with a robust Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

KRAS Inhibitors Market By Mutation Type (KRAS G12C, KRAS G12D, Other Mutations); By Cancer Type (NSCLC, Colorectal Cancer, Pancreatic Cancer, Other Cancers); By Drug Type (Monotherapy, Combination Therapy); By Route of Administration (Oral, Parenteral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global KRAS Inhibitors Market is projected to expand steadily over the next decade. Valued at roughly USD 2.1 billion in 2024, it is expected to surpass ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market By Target Protein (Amyloid-β, Tau, α-Synuclein, Huntingtin, TDP-43, Others); By Therapeutic Modality (Monoclonal Antibodies, RNA/Antisense Therapies, Small Molecule Modulators, Gene Therapy & Advanced Platforms); By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s, Rare Proteinopathies); By Line of Therapy; By Region, Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The global Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market is projected to reach USD 1.7 billion by 2035, up from around USD 0.6 billion in 2025, growing at... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, NSCLC); By Line of Therapy (First-Line, Second-Line, Maintenance/Combo Therapy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PLK Targeted Therapies Market is gaining traction in oncology drug development, with an CAGR of around 8.5% from 2024 to 2030, valued at USD 1.1 b... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market is projected to grow at a CAGR of 32.6%, starting at an estimated USD 318 million in 202... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a CAGR of 8.9%, valued at USD 1.5 billion in 2024, and expected to reach USD 2.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market is projected to expand steadily between 2024 and 2030, registering a CAGR of 10.4%, valued at around USD 1.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is estimated at USD 675 million in 2024 and is projected to reach USD 1.02 billion by 2030, growing at a CAG... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is on a sharp upward trajectory — currently valued at USD 472.5 million in 2024, and expected to climb to USD... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Selective Estrogen Receptor Degrader (SERD) Market By Product Type (Injectable SERDs, Oral SERDs); By Route of Administration (Intramuscular, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Selective Estrogen Receptor Degrader (SERD) Market will expand at an estimated CAGR of 8.9%Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

CDC7 Kinase Inhibitors Drugs Market By Drug Type (Small Molecule Inhibitors, Combination Therapies); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Route of Administration (Oral, Intravenous); By End User (Academic Hospitals, Cancer Centers, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CDC7 Kinase Inhibitors Drugs Market will register a robust CAGR of 18.2%, valued at $487 million in 2024, and is projected to reach Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

PROTAC Inhibitors Market By Type (Bifunctional PROTACs, Molecular Glue Degraders); By Therapeutic Area (Oncology, Neurodegenerative Diseases, Autoimmune Disorders); By End User (Academic & Research Institutes, Specialty Oncology Centers, CROs, Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PROTAC Inhibitors Market is poised to grow at a projected CAGR of 28.7%, valued at USD 417 million in 2024, and expected to cross Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

CD19 Antibody Market By Antibody Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates); By Application (Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Autoimmune Disorders, Others); By End User (Hospitals, Specialty Cancer Centers, Community Hospitals & Clinics, Outpatient Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD19 Antibody Market is set for considerable momentum, projected to grow at a compound annual growth rate (CAGR) of 14.8%, rising from an estimated USD 3.1 billion... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

STAT3 Inhibitors Market By Drug Type (Small Molecule Inhibitors, Antisense Oligonucleotides, Peptides, Protein Degraders); By Route of Administration (Oral, Injectable, Localized/Intratumoral); By Application (Oncology, Inflammatory Diseases, Fibrosis, Autoimmune Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global STAT3 Inhibitors Market is expected to grow steadily between 2024 and 2030, with an CAGR of around 6.5%. The market is estimated to reach... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

CD123 Targeted Therapy Market By Therapy Type (Antibody-Drug Conjugates, Monoclonal Antibodies, Bispecific Antibodies, CAR-T Therapies); By Application (Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Others); By End User (Academic & Research Hospitals, Cancer Specialty Centers, Community Hospitals & Clinics, CROs & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD123 Targeted Therapy Market is expected to reach a value of around USD 2.1 billion in 2024 and is projected to hit nearly USD 5.3 billion by 203... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485